United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News BioNTech and Pfizer forge $425m partnership to develop mRNA-based flu vaccines In a significant advancement in vaccine research, German biotech firm BioNTech has partnered with American pharmaceutical giant Pfizer… bypharmanewsdailyAugust 19, 2018
